Skip to main content
Erschienen in: World Journal of Urology 3/2014

01.06.2014 | Original Article

Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study

verfasst von: Zafer Tandogdu, Mete Cek, Florian Wagenlehner, Kurt Naber, Peter Tenke, Edgar van Ostrum, Truls Bjerklund Johansen

Erschienen in: World Journal of Urology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

To present the worldwide antibiotic resistance rates of uropathogens reported in nosocomial urinary tract infections (NAUTI) during the period of 2003–2010.

Materials and methods

Data from the Global Prevalence Study of Infections in Urology from the period of 2003–2010 were analyzed to evaluate the resistance rates of pathogens causing NAUTI. The web-based application was used to record data of investigators from urology departments participating in the study every year during the days allocated in November. Each center was allowed to enter data on a single day of the study. The point prevalence data was used to find differences among geographic regions and years by utilizing multiple logistic regression analysis.

Results

A total of 19,756 patients were hospitalized during the study period, and in 1,866 of them, NAUTI was reported. Proof of infection was reported in 1,395 patients. Resistance rates of all antibiotics tested other than imipenem against the total bacterial spectrum were higher than 10 % in all regions. Resistance to almost all pathogens was lowest in North Europe, and there is no single year where an outbreak of resistance has been detected.

Conclusion

The resistance rates of most of the uropathogens against the antibiotics tested did not show significant trends of increase or decrease with Asia exhibiting the highest rates in general. The only antibiotic tested with an overall resistance rate below 10 % was imipenem. Knowledge of regional and local resistance data and prudent use of antibiotics are necessary to optimize antibiotic therapy in urological patients with NAUTI.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Gastmeier P, Kampf G, Wischnewski N, Hauer T, Schulgen G, Schumacher M et al (1998) Prevalence of nosocomial infections in representative German hospitals. J Hosp Infect 38(1):37–49PubMedCrossRef Gastmeier P, Kampf G, Wischnewski N, Hauer T, Schulgen G, Schumacher M et al (1998) Prevalence of nosocomial infections in representative German hospitals. J Hosp Infect 38(1):37–49PubMedCrossRef
2.
Zurück zum Zitat Andrade SS, Sader HS, Jones RN, Pereira AS, Pignatari ACC, Gales AC (2006) Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines? Memórias do Instituto Oswaldo Cruz 101(7):741–748PubMedCrossRef Andrade SS, Sader HS, Jones RN, Pereira AS, Pignatari ACC, Gales AC (2006) Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines? Memórias do Instituto Oswaldo Cruz 101(7):741–748PubMedCrossRef
3.
Zurück zum Zitat Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J (1997) (2000) Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program. Antonie Van Leeuwenhoek 77(2):147–152CrossRef Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J (1997) (2000) Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program. Antonie Van Leeuwenhoek 77(2):147–152CrossRef
4.
Zurück zum Zitat Wagenlehner FME, Niemetz A, Dalhoff A, Naber KG (2002) Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994-2000. Int J Antimicrob Agents 19(6):557–564PubMedCrossRef Wagenlehner FME, Niemetz A, Dalhoff A, Naber KG (2002) Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994-2000. Int J Antimicrob Agents 19(6):557–564PubMedCrossRef
5.
Zurück zum Zitat Bjerklund Johansen TE, Cek M, Naber K, Stratchounski L, Svendsen MV, Tenke P (2007) Prevalence of hospital-acquired urinary tract infections in urology departments. Eur Urol 51(4):1100–1112PubMedCrossRef Bjerklund Johansen TE, Cek M, Naber K, Stratchounski L, Svendsen MV, Tenke P (2007) Prevalence of hospital-acquired urinary tract infections in urology departments. Eur Urol 51(4):1100–1112PubMedCrossRef
6.
Zurück zum Zitat Johansen TE, Cek M, Naber KG, Stratchounski L, Svendsen MV, Tenke P (2006) Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies. Int J Antimicrob Agents 28(Suppl 1):S91–S107PubMedCrossRef Johansen TE, Cek M, Naber KG, Stratchounski L, Svendsen MV, Tenke P (2006) Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies. Int J Antimicrob Agents 28(Suppl 1):S91–S107PubMedCrossRef
7.
Zurück zum Zitat Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36(5):309–332PubMedCrossRef Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36(5):309–332PubMedCrossRef
8.
Zurück zum Zitat Shaifali I, Gupta U, Mahmood SE, Ahmed J (2012) Antibiotic susceptibility patterns of urinary pathogens in female outpatients. N Am J Med Sci 4(4):163–169PubMedCentralPubMedCrossRef Shaifali I, Gupta U, Mahmood SE, Ahmed J (2012) Antibiotic susceptibility patterns of urinary pathogens in female outpatients. N Am J Med Sci 4(4):163–169PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Elhanan G, Sarhat M, Raz R (1997) Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection. J infect 35(3):283–288PubMedCrossRef Elhanan G, Sarhat M, Raz R (1997) Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection. J infect 35(3):283–288PubMedCrossRef
10.
Zurück zum Zitat Cullen IM, Manecksha RP, McCullagh E, Ahmad S, O’Kelly F, Flynn RJ et al (2012) The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009. BJU int 109(8):1198–1206PubMedCrossRef Cullen IM, Manecksha RP, McCullagh E, Ahmad S, O’Kelly F, Flynn RJ et al (2012) The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009. BJU int 109(8):1198–1206PubMedCrossRef
11.
Zurück zum Zitat Kahlmeter G, Poulsen HOn (2012) Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited. Int J Antimicrob Agents 39(1):45–51PubMedCrossRef Kahlmeter G, Poulsen HOn (2012) Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited. Int J Antimicrob Agents 39(1):45–51PubMedCrossRef
12.
Zurück zum Zitat Bonkat G, M√ºller G, Braissant O, Frei R, Tschudin-Suter S, Rieken M, et al (2013) Increasing prevalence of ciprofloxacin resistance in extended-spectrum-ß-lactamase-producing Escherichia coli urinary isolates. World journal of urology Bonkat G, M√ºller G, Braissant O, Frei R, Tschudin-Suter S, Rieken M, et al (2013) Increasing prevalence of ciprofloxacin resistance in extended-spectrum-ß-lactamase-producing Escherichia coli urinary isolates. World journal of urology
13.
Zurück zum Zitat Nys S, Terporten PH, Hoogkamp-Korstanje JAA, Stobberingh EE, Group SSS (2008) Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998–2005). J antimicrobial chemotherapy 62(1):126–132CrossRef Nys S, Terporten PH, Hoogkamp-Korstanje JAA, Stobberingh EE, Group SSS (2008) Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998–2005). J antimicrobial chemotherapy 62(1):126–132CrossRef
14.
Zurück zum Zitat Peña C, Pujol M, Ricart A, Ardanuy C, Ayats J, Liñares J et al (1997) Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect 35(1):9–16PubMedCrossRef Peña C, Pujol M, Ricart A, Ardanuy C, Ayats J, Liñares J et al (1997) Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect 35(1):9–16PubMedCrossRef
15.
Zurück zum Zitat Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO (2001) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32(8):1162–1171PubMedCrossRef Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO (2001) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32(8):1162–1171PubMedCrossRef
16.
Zurück zum Zitat Akduman B, Akduman D, Tokgöz H, Erol B, Türker T, Ayoğlu F et al (2011) Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms. Urology 78(2):250–255PubMedCrossRef Akduman B, Akduman D, Tokgöz H, Erol B, Türker T, Ayoğlu F et al (2011) Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms. Urology 78(2):250–255PubMedCrossRef
17.
Zurück zum Zitat Cek M, Tandoğdu Z, Naber K, Tenke P, Wagenlehner F, van Oostrum E, et al (2012) Antibiotic Prophylaxis in Urology Departments, 2005–2010. Eur Urol 63(2):386–394 Cek M, Tandoğdu Z, Naber K, Tenke P, Wagenlehner F, van Oostrum E, et al (2012) Antibiotic Prophylaxis in Urology Departments, 2005–2010. Eur Urol 63(2):386–394
Metadaten
Titel
Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study
verfasst von
Zafer Tandogdu
Mete Cek
Florian Wagenlehner
Kurt Naber
Peter Tenke
Edgar van Ostrum
Truls Bjerklund Johansen
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 3/2014
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-013-1154-8

Weitere Artikel der Ausgabe 3/2014

World Journal of Urology 3/2014 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.